Genetics of drug resistance

Epilepsia

Volumn 46, Issue SUPPL. 10, 2005, Pages 33-38

  Sisodiya, Sanjay M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antiepileptic drugs; Association studies; Drug resistance; Epilepsy; Genetics

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ANTICONVULSIVE AGENT; APOLIPOPROTEIN E; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CYTOCHROME P450; ETIRACETAM; GLYCOPROTEIN P; INTERLEUKIN 1BETA; LAMOTRIGINE; MULTIDRUG RESISTANCE PROTEIN 1; NEUROPEPTIDE Y RECEPTOR; PHENYTOIN; PREGABALIN; PRION PROTEIN; PRODYNORPHIN; ENKEPHALIN; INTERLEUKIN 1; PREPROENKEPHALIN; PROTEIN PRECURSOR;

ANTICONVULSANT THERAPY; CONFERENCE PAPER; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EPILEPSY; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC VARIABILITY; HUMAN; MOLECULAR MECHANICS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; DRUG RESISTANCE; GENETICS; METHODOLOGY; MULTICENTER STUDY; MUTATION; NOMENCLATURE; PHARMACOGENETICS; PRION; REVIEW;

ANTICONVULSANTS; APOLIPOPROTEINS E; DRUG RESISTANCE; ENKEPHALINS; EPILEPSY; HUMANS; INTERLEUKIN-1; MULTICENTER STUDIES; MUTATION; P-GLYCOPROTEINS; PHARMACOGENETICS; PRIONS; PROTEIN PRECURSORS; RECEPTORS, GABA-B; RESEARCH DESIGN; TERMINOLOGY; VARIATION (GENETICS);

EID: 33644807970     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2005.00356.x     Document Type: Conference Paper

References (39)

1. Loescher W, Schmidt D. New horizons in the development of antiepileptic drugs: the search for new targets. Epilepsy Res 2004;60:77-159.
2. Remy S, Urban BW, Elger CE, et al. Anticonvulsant pharmacology of voltage-gated Na+ channels in hippocampal neurons of control and chronically epileptic rats. Eur J Neurosci 2003;17:2648-58.
3. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-9.
4. Remy S, Gabriel S, Urban BW, et al. A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 2003;53:469-79.
5. Ceulemans BP, Claes LR, Lagae LG. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy. Pediatr Neurol 2004;30:236-43.
6. Mulley JC, Scheffer IE, Petrou S, et al. Channelopathies as a genetic cause of epilepsy. Curr Opin Neurol 2003;16:171-6.
7. Kamiya K, Kaneda M, Sugawara T, et al. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J Neurosci 2004;24:2690-8.
8. Lee CR, Goldstein JA, Pieper JA. Pharmacogenetics 2002;12:251-63.
9. Lohmueller KE, Pearce CL, Pike M, et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
10. Hirschhorn JN, Lohmueller K, Byrne E, et al. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61.
11. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361:865-72.
12. Tan NC, Mulley JC, Berkovic SF. Genetic association studies in epilepsy: "the truth is out there." Epilepsia 2004;45:1429-42.
13. Kanemoto K, Kawasaki J, Miyamoto T, et al. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000;47:571-4.
14. Heils A, Haug K, Kunz WS, et al. Interleukin-1beta gene polymorphism and susceptibility to temporal lobe epilepsy with hippocampal sclerosis. Ann Neurol 2000;48:948-50.
15. Jin L, Jia Y, Zhang B, et al. Association analysis of a polymorphism of interleukin 1 beta (IL-1 beta) gene with temporal lobe epilepsy in a Chinese population. Epilepsia 2003;44:1306-9.
16. Buono RJ, Ferraro TN, O'Connor MJ, et al. Lack of association between an interleukin 1 beta (IL-1beta) gene variation and refractory temporal lobe epilepsy. Epilepsia 2001;42:782-4.
17. Peltola J, Keranen T, Rainesalo S, et al. Polymorphism of the interleukin-1 gene complex in localization-related epilepsy. Ann Neurol 2001;50:275-6.
18. Cavalleri G, Lynch JM, Depondt C, et al. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here? Brain 2005;128:1832-40.
19. Stogmann E, Zimprich A, Baumgartner C, et al. A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy. Ann Neurol 2002;51:260-3.
20. Tilgen N, Rebstock J, Horvath S, et al. Prodynorphin gene promoter polymorphism and temporal lobe epilepsy. Ann Neurol 2003;53:280-1.
21. Gambardella A, Manna I, Labate A, et al. Prodynorphin gene promoter polymorphism and temporal lobe epilepsy. Epilepsia 2003;44:1255-6.
22. Gambardella A, Manna I, Labate A, et al. GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 2003;60:560-3.
23. Walz R, Amaral OB, Rockenbach IC, et al. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 1999;40:1679-82.
24. Walz R, Castro RM, Velasco TR, et al. Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant. Neurology 2003;61:1204-10.
25. Mead S, Stumpf MP, Whitfield J, et al. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 2003;300:640-3.
26. Briellmann RS, Torn-Broers Y, Busuttil BE, et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000;55:435-7.
27. Blumcke I, Brockhaus A, Scheiwe C, et al. The apolipoprotein E epsilon 4 allele is not associated with early onset temporal lobe epilepsy. Neuroreport 1997;8:1235-7.
28. Gambardella A, Aguglia U, Cittadella R, et al. Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia 1999;40:1804-7.
29. Siddiqui A, Kerb R, Weale ME, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003;348:1442-8.
30. Tan NC, Heron SE, Scheffer IE, et al. Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 2004;63:1090-2.
31. Zimprich F, Sunder-Plassmann R, Stogmann E, et al. Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy. Neurology 2004;63:1087-9.
32. Sisodiya SM. Mechanisms of antiepileptic drug resistance. Curr Opin Neurol 2003;16:197-201.
33. Loscher W, Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 2002;301:7-14.
34. Soranzo N, Cavalleri G, Wood NW, et al. Identifying candidate causal variants responsible for altered activity of the ABCB1 multi-drug resistance gene product. Genome Res 2004;14:1333-44.
35. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;20;350:2129-39.
36. Price DK, Figg WD. Mutations in the EGFR: the Importance of Genotyping. Cancer Biol Ther 2004;3:434-5.
37. Goldstein DB, Tate SK, Sisodiya SM. Pharmacogenetics goes genomic. Nat Rev Genet 2003;4:937-47.
38. Roses AD. Pharmacogenetics and drug development: the path to safer and more effective drugs. Nat Rev Genet 2004;5:645-56.
39. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004;75:353-62.